Wu Yajun’s net worth, biography, fact, career, awards and life story

Net Worth: $9 Billion
Gender: Female
Last Updated: 2019

Wu Yajun net worth: Wu Yajun is a Chinese self-made billionaire who has a net worth of $9 billion. Wu Yajun is just a handful of self-made female Chinese billionaires. Wu earned a degree in engineering from Northwestern Polytechnic University in 1984. She served as a journalist and editor at the China Shirong News Agency from 1988 to 1993. Yajun’s real success and the status she currently holds came from her involvement in real estate. In 1994, she founded the now publicly traded real estate developer Longfor Properties. She founded the company with her second husband Cai Kui, whom she divorced in 2012. Her company has been growing rapidly over the years, expanding from her initial base in Chongqing to major cities like Chengdu, Beijing, Shanghai, Changzhou and Dalian. The couple had controlled 72% of the company’s shares until their separation, when Mr. Cai received 40% of the shares. Wu is currently divorced and doesn’t have any children. By 2013 her net worth topped $3 billion. By 2015 it topped $5 billion. As of this writing Wu Yajun’s net worth is $9 billion.

You May Also Like

Dilip Shanghvi’s net worth, biography, fact, career, awards and life story

Dilip Shanghvi net worth: Dilip Shanghvi is an Indian pharmaceutical entrepreneur who has a net worth of $16 billion. Dilip Shanghvi is the founder and managing director of Sun Pharmaceutical Industries Limited. Ever since its creation in 1982, Sun Pharma has developed into the fifth-largest drug-maker in India. However, he saw his fortune swell when the company’s shares managed to gain 40% in 12 months. Thanks to his BA degree from the University of Calcutta and his extensive experience in the pharmaceutical industry, Shanghvi succeeded to build India’s most valuable drug-producer in less than three decades. Furthermore, he is the Chairman of Sun Pharma`s primary American subsidiary, Caraco, which concluded $230 million acquisition of Nasdaq-listed skincare firm DUSA Pharmaceuticals and inked a deal to buy a US generics business of Japan’s Takeda Pharmaceuticals for an undisclosed sum. As for his private life, he is married with two children. Net Worth details: Dilip Shanghvi owns 54 percent of Sun Pharmaceutical Industries which includes his family’s shares since he is the founder and managing director of the specialty generic drug maker. Shanghvi also owns 67 percent of Sun Pharma Advanced Research and 14 percent of drug and medical technology company BioLight Life Sciences. He owns 20 percent of Suzion Energy which he paid $289 million for, and 3 percent of Natco Pharma.
Read More